Our goal is to leverage IRB Barcelona research as a powerful driving force for the wellbeing, whether in the form of diagnostic tools, new medicines and technologies, or even employment opportunities. We are advised by an international Business Advisory Board.
The Innovation team is here to assist IRB Barcelona members in protecting and commercialising their research. Contact us for activities related to legal documents, industrial collaborations, patenting, licensing and/or setting up a spin-off company.
Innovation Facts & Figures
Priority patent applications
«One of the parameters for where I wanted to work was how easy it would be to start a spinoff, Barcelona—and the IRB— seemed to be a great place to go.»
Founder of Omnia Molecular
«Our project, Colostage, aims to prevent patients who aren't at risk of developing metastasis from undergoing chemotherapy treatments which can be costly, unnecessary, and very aggressive. Our test will really help doctors chose the best choice of treatment for their patients. At the same time it will lead to substantial savings for the healthcare systems.»
More about this here.
«The innovation course has been one of the best experiences during my PhD at IRB Barcelona. It gave me insights into business development in the biotechnology sector, encouraging me to do science in a way that I found particularly attractive.»
«If you have good knowledge of science and the skills to organise and lead a team, you can do other exciting and interesting things besides research.»
Co-founder of Iproteos.
«Inbiomotion is an example of how academic basic research can provide grounds to address an unmet medical need, making a step forward in the clinical standard of care using personalized medicine to prevent cancer metastasis.»
Founder of Inbiomotion
«One of my goals when choosing IRB Barcelona was also to gain experience in tech transfer. I have ideas. And I want to learn how to convert them into a business.»
«Sometimes the best way to make research useful for society is to publish and bring new knowledge into public domain. In addition, we need to patend discoveries to guarantee their commercialization and provide incentives for pharmaceutical companies to develop drugs.»